Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Positive NICE recommendations for rivaroxaban and denosumab

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Positive NICE recommendations for rivaroxaban and denosumab. Pharmacoecon. Outcomes News 651, 11 (2012). https://doi.org/10.2165/00151234-201206510-00035

    Download citation

    Keywords

    • Prostate Cancer
    • Atrial Fibrillation
    • Zoledronic Acid
    • Zoledronic
    • Dabigatran